Premium content

Blood biomarker predicted MS disability progress two years in advance

Published

4 weeks ago

9 November 2023

Multiple sclerosis (MS) patients with elevated levels of nerve biomarker NfL in their blood are at an increased risk of worsening disability within two years, new research led by UC San Francisco suggests.

Unlock this article and more exclusive content every day as an NR Times subscriber. Just £24.99 / $30 / €28 per year.

Related Topics:Featured Multiple sclerosis (MS)

Up Next

Lightweight gloves use electronic stimulation to reduce Parkinson’s tremors

Don't Miss

Research reveals brain area’s role in recognising others

News1 week ago

Compassion focused therapy: Lessons from the frontline of brain injury care

Case management3 weeks ago

Making client dreams come true

Premium content4 weeks ago

Concussion in sports: new innovations poised to transform the landscape

Inpatient rehab2 weeks ago

Introducing Chislehurst

Professional Insight4 weeks ago

Dealing with ambiguous loss

Brain injury1 week ago

Heading football ‘linked to measurable brain decline’

Brain injury1 week ago

Can the eye hold the key to brain injury detection?

Stroke2 weeks ago

‘It’s easy to look OK when you’re not OK’

Cookie	Duration	Description
__cfduid	1 month	The cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.
_GRECAPTCHA	5 months 27 days	This cookie is set by Google. In addition to certain standard Google cookies, reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement		The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics		This cookies is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
iutk	5 months 27 days	This cookie is used by Issuu analytic system. The cookies is used to gather information regarding visitor activity on Issuu products.

Cookie	Duration	Description
cookielawinfo-checkbox-functional	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others		No description
lfuuid	9 years 11 months	Third party (Lead Forensics) cookie which enables us to track visitor behaviour on our site. Tracking is performed anonymously until a user identifies themselves by submitting a form.
S	1 hour	No description

Neuro Rehab Times

Blood biomarker predicted MS disability progress two years in advance

Premium content

Blood biomarker predicted MS disability progress two years in advance

Unlock this article and more exclusive content every day as an NR Times subscriber. Just £24.99 / $30 / €28 per year.

Trending

Neuro Rehab Times

Blood biomarker predicted MS disability progress two years in advance

Unlock this article and more exclusive content every day as an NR Times subscriber. Just £24.99 / $30 / €28 per year.

You may like

Trending